Tanke Biosciences Corp TNBI
OTC · stock · Grain Mill Products · website · IPO 2011-02-10
Tanke Biosciences Corp statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2012 | FY2011 | FY2010 |
|---|---|---|---|
| Gross margin | 34.8% | 36.8% | 36.8% |
| Operating margin | 15.9% | 7.3% | 21.8% |
| Net margin | -0.7% | -13.2% | 13.6% |
| FCF margin | -7.1% | 11.9% | 21.4% |
| Return on assets | -0.7% | -12.6% | 20.6% |
| Return on equity | -1.3% | -19.8% | 26.5% |
| Debt / equity | 0.13× | 0.09× | 0.04× |
| Current ratio | 1.85 | 5.33 | 3.19 |
Source: SEC EDGAR filings · CIK 0001452011 · US · as of 2012-12-31. facts plus Stocktoria's own computed scores — not investment advice.